Beddow Capital Management Inc Bristol Myers Squibb CO Transaction History

Beddow Capital Management Inc

$267 Million
Q1 2025

A detailed history of Beddow Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beddow Capital Management Inc holds 4,875 shares of BMY stock, worth $218,497. This represents 0.11% of its overall portfolio holdings.

Number of Shares

4,875

Previous 12,880 62.15%

Holding current value

$218,497

Previous $728,000 59.2%

% of portfolio

0.11%

Previous 0.3%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$53.9 - $63.11 $431,469 - $505,195	-8,005 Reduced 62.15%	4,875 $297,000
Q4 2024 Feb 11, 2025	SELL	$51.92 - $59.94 $110,070 - $127,072	-2,120 Reduced 14.13%	12,880 $728,000
Q3 2024 Nov 07, 2024	SELL	$39.66 - $51.75 $755,721 - $986,096	-19,055 Reduced 55.95%	15,000 $776,000
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $56,350 - $74,186	1,400 Added 4.29%	34,055 $1.41 Million
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $179,877 - $203,945	3,749 Added 12.97%	32,655 $1.77 Million
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $1.37 Million - $1.64 Million	-28,323 Reduced 49.49%	28,906 $1.48 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $85,735 - $95,865	-1,481 Reduced 2.52%	57,229 $3.32 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $7,963 - $8,842	125 Added 0.21%	58,710 $3.76 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $49,282 - $55,897	750 Added 1.3%	58,585 $4.06 Million
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $11,984 - $14,190	-175 Reduced 0.3%	57,835 $4.16 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $65 - $38,420	500 Added 0.87%	58,010 $4.12 Million
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $164,121 - $180,754	2,260 Added 4.09%	57,510 $4.43 Million
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $124,497 - $149,283	2,025 Added 3.8%	55,250 $4.04 Million
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $510,825 - $595,503	9,525 Added 21.8%	53,225 $3.32 Million
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $2.59 Million - $3.03 Million	43,700 New	43,700 $2.59 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $1.81 Million - $2.05 Million	-31,345 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $40,201 - $44,548	-700 Reduced 2.18%	31,345 $1.89 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $280,952 - $328,461	-5,125 Reduced 13.79%	32,045 $1.88 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $125,744 - $182,735	-2,710 Reduced 6.8%	37,170 $2.07 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $84,149 - $109,764	1,710 Added 4.48%	39,880 $2.56 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $9,837 - $11,663	-230 Reduced 0.6%	38,170 $1.94 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $475,649 - $525,964	-10,660 Reduced 21.73%	38,400 $1.74 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $1.35 Million - $1.61 Million	30,005 Added 157.47%	49,060 $1.77 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $929,121 - $1.2 Million	19,055 New	19,055 $360,000

Others Institutions Holding BMY

# of Institutions

2,706

Shares Held

1.58B

Call Options Held

25.9M

Put Options Held

24.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $95.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beddow Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Beddow Capital Management Inc with notifications on news.

Account

Beddow Capital Management Inc Bristol Myers Squibb CO Transaction History